- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
End of an Era as Cell Editor Steps Down
15 September 1999 7:30 pm
Benjamin Lewin, the editor of Cell and its sister journal Molecular Cell, announced to his staff and editorial board yesterday that he plans to retire on 1 October. His sudden departure represents "a big loss for Cell," says cell biologist Tony Hunter of the Salk Institute for Biological Studies in La Jolla, California. Reached by ScienceNOW, Lewin declined to comment, other than to deny rumors that he is ill.
After Lewin founded Cell in 1974, it quickly became a premier journal of molecular and cell biology. Scientists attribute the journal's success largely to Lewin's depth of scientific knowledge and hands-on management style. "It will be very different without Benjamin there," says Hunter, who has been on the journal's editorial board since 1980. "He was always there to talk with you about your paper or someone else's. This was in contrast with most other journals."
Lewin sold the journal, along with its three sister journals--Neuron, Immunity, and Molecular Cell--to Dutch science-publishing giant Elsevier Science in April, for an amount rumored to be close to $100 million. Insiders wondered how long Lewin would stay on, although Elsevier had announced he would remain editor for 5 years. Now, Deputy Editor Vivian Siegel will take over the helm, but some close to the journal suspect Lewin's departure, combined with Elsevier's takeover, will trigger an exodus of editorial staff.
"I don't think Cell can be Cell without Lewin," says molecular biologist Robert Tjian, also a member of the journal's editorial board. It is too early to tell whether individual editorial board members will stay on, he says.